Literature DB >> 18685510

Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells.

Michele Pier Luca Guarino1, Annamaria Altomare, Elisa Stasi, Massimo Marignani, Carola Severi, Rossana Alloni, Giordano Dicuonzo, Lorenzo Morelli, Roberto Coppola, Michele Cicala.   

Abstract

AIM: To define whether human colonic mucosa exposure to Lactobacillus rhamnosus GG (LGG), American Type Culture Collection (ATCC) 53103, may influence intestinal muscle cell contractility.
METHODS: Human colon specimens were obtained from disease-free margins of resected segments for cancer. The mucosa and submucosa, after dissection, were sealed between 2 chambers, with the luminal side of the mucosa facing upward and covered with 5 mL of Krebs solution and the submucosal side facing downward into 20 mL of Krebs solution. LGG or normal undernatant (N-undernatant) were added to the luminal side of the mucosa for 30 minutes. Smooth muscle cells (SMCs), isolated from the circular muscle layer, were exposed to undernatant for 30 minutes from the submucosal chamber of mucosa that was either preexposed to N-undernatant or to LGG (36 x 10(-9) colony forming units/mL) (LGG-undernatant). Acetylcholine (Ach) dose-response was obtained for SMCs.
RESULTS: SMCs exposed to N-undernatant presented a dose-response to Ach (maximal contraction: 32%+/-5% with 1-muM Ach) that is similar to unstimulated SMCs. Exposure to LGG-undernatant resulted both in an 18%+/-3% cell shortening and a 78%+/-7% inhibition of maximal Ach-induced contraction. When SMCs were directly exposed to LGG, a significant impairment of contraction (70%+/-5%, compared with control cells) and a dose-dependent and time-dependent shortening were observed.
CONCLUSIONS: After acute exposure of colonic mucosa to LGG, a significant shortening of SMCs is observed that possibly contributes to the reduced contractile response to Ach. Further studies are needed to establish the mechanisms of this effect that could account for the clinical efficacy of probiotics in intestinal disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18685510     DOI: 10.1097/MCG.0b013e31817e1cac

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

Review 1.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 3.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

4.  Effects of Synbiotic2000™ Forte on the Intestinal Motility and Interstitial Cells of Cajal in TBI Mouse Model.

Authors:  Limei Zhang; Jing Zeng; Yuanyuan Ma; Min Tan; Min Zhou; Huan Fang; Stig Bengmark; Jingci Zhu
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

5.  Basic and translational understandings of microbial recognition by toll-like receptors in the intestine.

Authors:  Sang Hoon Rhee
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

6.  Lactobacillus rhamnosus GG normalizes gut dysmotility induced by environmental pollutants via affecting serotonin level in zebrafish larvae.

Authors:  Ju Wang; Lifen Yin; Wenxiu Zheng; Shengnan Shi; Wenzhuo Hao; Changhong Liu; Lei Zheng
Journal:  World J Microbiol Biotechnol       Date:  2022-09-14       Impact factor: 4.253

7.  Starring role of toll-like receptor-4 activation in the gut-liver axis.

Authors:  Simone Carotti; Michele Pier Luca Guarino; Umberto Vespasiani-Gentilucci; Sergio Morini
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

8.  Irritable bowel syndrome, gut microbiota and probiotics.

Authors:  Beom Jae Lee; Young-Tae Bak
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

9.  Characterization of Microbiota in Children with Chronic Functional Constipation.

Authors:  Tim G J de Meij; Evelien F J de Groot; Anat Eck; Andries E Budding; C M Frank Kneepkens; Marc A Benninga; Adriaan A van Bodegraven; Paul H M Savelkoul
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

10.  Antioxidant activity of inulin and its role in the prevention of human colonic muscle cell impairment induced by lipopolysaccharide mucosal exposure.

Authors:  Valentina Pasqualetti; Annamaria Altomare; Michele Pier Luca Guarino; Vittoria Locato; Silvia Cocca; Sara Cimini; Rossella Palma; Rossana Alloni; Laura De Gara; Michele Cicala
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.